| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 64 |
| 1 | ASPIRIN 325 MG | 63 |
| 2 | ASPIRIN 81 MG | 63 |
| 3 | CLOPIDOGREL | 63 |
| 4 | CLOPIDOGREL BISULFATE | 61 |
| 5 | TIROFIBAN | 21 |
| 6 | EVOLOCUMAB | 15 |
| 7 | ROSUVASTATIN | 9 |
| 8 | EZETIMIBE | 8 |
| 9 | ATORVASTATIN CALCIUM | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANGRELOR | 3 | 0.0074 |
| 1 | TIROFIBAN | 21 | 0.0072 |
| 2 | BIVALIRUDIN | 1 | 0.0010 |
| 3 | CILOSTAZOL | 6 | 0.0010 |
| 4 | GADODIAMIDE | 3 | 0.0009 |
| 5 | SALINE NASAL SPRAY | 3 | 0.0007 |
| 6 | TENECTEPLASE | 1 | 0.0006 |
| 7 | CLOPIDOGREL BISULFATE | 61 | 0.0006 |
| 8 | CEFADROXIL | 1 | 0.0005 |
| 9 | AMLODIPINE BESYLATE AND VALSARTAN | 5 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Phosphodiesterase 3 Inhibitor [EPC] | 6 | 0.0010 |
| 1 | Paramagnetic Contrast Agent [EPC] | 3 | 0.0007 |
| 2 | PCSK9 Inhibitor [EPC] | 15 | 0.0006 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 67 | 0.0006 |
| 4 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 5 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 6 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 64 | 0.0001 |
| 8 | Vitamin D Analog [EPC] | 2 | 0.0001 |
| 9 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |